Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Sovaldi
Sovaldi
Gilead expects big increase in Europeans treated with hep C drug
Yahoo/Reuters
Wed, 02/11/15 - 09:50 am
Gilead Sciences
Europe
hepatitis C
Sovaldi
Harvoni
Gilead faces challenge to European patent on pricey hep C drug
Yahoo/Reuters
Tue, 02/10/15 - 10:21 am
Gilead Sciences
Europe
patents
hepatitis C
Sovaldi
Big Pharma Faces Some Big Patent Losses, but Pipelines are Improving
WSJ Pharmalot
Tue, 02/10/15 - 08:41 am
patents
Big Pharma
Abilify
Amgen
AstraZeneca
Biogen Idec
Bristol-Myers Squibb
Crestor
Eli Lilly
Gilead Sciences
GSK
Harvoni
Hospira
Merck
Novo Nordisk
Pfizer
Sovaldi
Tecfidera
Achillion HCV-1 regimen achieves 100% SVR12 at six weeks
Seeking Alpha
Mon, 02/9/15 - 08:26 am
Achillion
hepatitis C
ACH-3102
Gilead Sciences
Sovaldi
Bigger drug discounts put question mark over Gilead's stellar run
Fortune
Wed, 02/4/15 - 10:18 am
Gilead Sciences
drug discounts
hepatitis C
Sovaldi
Harvoni
In cystic fibrosis drug launch prep, Vertex learns from Sovaldi mistakes
Bizjournals.com
Sat, 01/31/15 - 09:58 am
cystic fibrosis
Vertex Pharmaceuticals
Sovaldi
drug launches
Gilead Sciences
lumacaftor
Gilead Sciences, Inc. Continues To Reign Over The Hepatitis C Market
Bidness Etc.
Fri, 01/30/15 - 08:05 am
Gilead Sciences
AbbVie
Harvoni
Sovaldi
hepatitis C
Viekira Pak
Can Gilead Beat AbbVie At Its Own Game?
Seeking Alpha
Thu, 01/29/15 - 07:28 am
Gilead
AbbVie
hepatitis C
Harvoni
Sovaldi
Viekira Pak
Express Scripts
Gilead to Allow Generic-Drug Makers to Produce New Hepatitis C Treatment
WSJ Online
Mon, 01/26/15 - 07:52 am
generics
Gilead Sciences
hepatitis C
Sovaldi
India
Patients Blame Cost for Coverage Delay in England of Gilead Drug
WSJ Pharmalot
Fri, 01/23/15 - 08:21 am
UK
Gilead Sciences
patients
Sovaldi
hepatitis C
Gilead, AbbVie Hep C Price Cuts Seen Hitting Sales
Investors.com
Wed, 01/21/15 - 05:42 pm
Gilead Sciences
AbbVie
hepatitis C
drug pricing
Viekira Pak
Harvoni
Sovaldi
Can Gilead Sciences Beat Hep-C Estimates?
Barron's
Tue, 01/20/15 - 03:59 pm
Gilead Sciences
hepatitis C
Harvoni
Sovaldi
Gilead's appeal for drug patent in India could see protracted case
The Hindu
Sat, 01/17/15 - 11:05 am
Gilead Sciences
India
hepatitis C
Sovaldi
Aetna backs Gilead's hepatitis C treatment, gets discount
Reuters
Sat, 01/17/15 - 11:03 am
Aetna
Gilead Sciences
hepatitis C
AbbVie
Sovaldi
Harvoni
Viekira Pak
Gilead to appeal India patent ruling on hepatitis C drug
Yahoo/Reuters
Fri, 01/16/15 - 08:11 am
Gilead Sciences
India
patents
Sovaldi
hepatitis C
India Rejects Gilead Patent Bid for Sovaldi Hepatitis C Treatment
WSJ Pharmalot
Thu, 01/15/15 - 08:59 am
India
patents
Gilead Sciences
Sovaldi
hepatitis C
CVS Picks Gilead Hep C Drugs As Price War Looms
Investors.com
Mon, 01/5/15 - 04:04 pm
CVS
Gilead Sciences
Express Scripts
AbbVie
drug pricing
hepatitis C
Harvoni
Sovaldi
Why Gilead Sciences, Inc. Stock Plunged as Much as 14% in December
Motley Fool
Mon, 01/5/15 - 10:38 am
Gilead Sciences
AbbVie
Harvoni
Sovaldi
Express Scripts
hepatitis C
How 1 Tiny Hepatitis C Drug Developer Trounced Gilead Sciences, Inc. in 2014
Motley Fool
Fri, 01/2/15 - 08:26 am
hepatitis C
Gilead Sciences
Regulus
Harvoni
Sovaldi
RG-101
Gilead is Accused of Price Gouging, but is There Really a Legal Argument?
WSJ Pharmalot
Fri, 12/19/14 - 10:56 am
Gilead Sciences
Harvoni
drug pricing
Sovaldi
Pages
« first
‹ previous
…
3
4
5
6
7
8
9
10
11
…
next ›
last »